scholarly journals Psychiatric Case Review and Treatment Intensification in Collaborative Care Management for Depression in Primary Care

2018 ◽  
Vol 69 (5) ◽  
pp. 549-554 ◽  
Author(s):  
Nathaniel A. Sowa ◽  
Philip Jeng ◽  
Amy M. Bauer ◽  
Joseph M. Cerimele ◽  
Jürgen Unützer ◽  
...  
2019 ◽  
Author(s):  
Angela Nikelski ◽  
Armin Keller ◽  
Fanny Schumacher-Schönert ◽  
Terese Dehl ◽  
Jessica Laufer ◽  
...  

Abstract BackgroundSectorization of health care systems causes inefficient treatment, especially for elderly people with cognitive impairments. The transition from hospital care to primary care is insufficiently coordinated, and communication between health care providers is often lacking. Consequences include a further deterioration of health, higher rates of hospital readmission, and institutionalization. Models of collaborative care have shown their efficacy in primary care by improving patient-related outcomes. The main goal of this trial is to test the effectiveness of a collaborative care model for people with cognitive impairment (PCI) and current hospital treatment due to a somatic illness to improve the continuity of treatment and care across the transition between the in-hospital and adjoining primary care sectors.Methods The trial is a longitudinal multisite randomized controlled trial with two arms (“care as usual” and “intersectoral care management”). Inclusion criteria at the time of hospital admission due to a somatic illness: age 70+, cognitive impairment (Mini Mental State Examination, MMSE ≤ 26), live at home, provide written informed consent. Each participant will have a baseline assessment at the hospital and two follow-up assessments at home (three and twelve months after discharge). The estimated sample size is n=398 participants together with (where available) their respective informal caregivers.In the intersectoral care management group, specialized care managers will develop, implement and monitor individualized treatment and care based on comprehensive assessments of the patients and informal caregivers for unmet needs at the hospital and in their homes. Primary outcomes are (1) activities of daily living, (2) readmission to the hospital, and (3) institutionalization. Secondary outcomes include (a) frailty, (b) delirium, (c) quality of life, (d) cognitive status, (e) behavioral and psychological symptoms of dementia, (f) utilization of services, and (g) informal caregiver burden.DiscussionIn the event of proving efficacy, this trial delivers proof of concept for implementation into routine care. Cost-effectiveness analyses as well as an independent process evaluation increase the likelihood of meeting this goal. The trial allows in-depth analysis of mediating and moderating effects for different health outcomes at the interface between hospital care and primary care. Highlighting treatment and care, the study will provide insights into unmet needs at the time of hospital admission, the opportunities and barriers to meeting those needs during the hospital stay and after discharge.Trial registration ClinicalTrials.gov Identifier: NCT03359408


2016 ◽  
Vol 29 (1) ◽  
pp. 10-17 ◽  
Author(s):  
G. M. Garrison ◽  
K. B. Angstman ◽  
S. S. O'Connor ◽  
M. D. Williams ◽  
T. W. Lineberry

2019 ◽  
Vol 10 ◽  
pp. 215013271986126 ◽  
Author(s):  
Joseph A. Akambase ◽  
Nathaniel E. Miller ◽  
Gregory M. Garrison ◽  
Paul Stadem ◽  
Heather Talley ◽  
...  

Background: Depression is common in the primary care setting and tobacco use is more prevalent among individuals with depression. Recent research has linked smoking to poorer outcomes of depression treatment. We hypothesized that in adult primary care patients with the diagnosis of depression, current smoking would have a negative impact on clinical outcomes, regardless of treatment type (usual primary care [UC] vs collaborative care management [CCM]). Methods: A retrospective chart review study of 5155 adult primary care patients with depression in a primary care practice in southeast Minnesota was completed. Variables obtained included age, gender, marital status, race, smoking status, initial Patient Health Questionnaire–9 (PHQ-9), and 6-month PHQ-9. Clinical remission (CR) was defined as 6-month PHQ-9 <5. Persistent depressive symptoms (PDS) were defined as PHQ-9 ≥10 at 6 months. Treatment in both CCM and UC were compared. Results: Using intention to treat analysis, depressed smokers treated with CCM were 4.60 times as likely (95% CI 3.24-6.52, P < .001) to reach CR and were significantly less likely to have PDS at 6 months (adjusted odds ratio [AOR] 0.19, 95% CI 0.14-0.25, P < .001) compared with smokers in UC. After a 6-month follow-up, depressed smokers treated with CCM were 1.75 times as likely (95% CI 1.18-2.59, P = .006) to reach CR and were significantly less likely to have PDS (AOR 0.45, 95% CI 0.31-0.64, P < .001) compared with smokers in UC. Conclusions: CCM significantly improved depression outcomes for smokers at 6 months compared with UC. However, in the UC group, smoking outcomes were not statistically different at 6 months for either remission or PDS. Also, nonsmokers in CCM had the best clinical outcomes at 6 months in both achieving clinical remission and reduction of PDS when compared with smokers in UC as the reference group.


2014 ◽  
Vol 126 (2) ◽  
pp. 141-146 ◽  
Author(s):  
Ramona S. DeJesus ◽  
Lisa Howell ◽  
Mark Williams ◽  
Julie Hathaway ◽  
Kristin S. Vickers

2014 ◽  
Vol 17 (3) ◽  
pp. 180-184 ◽  
Author(s):  
Matthew R. Meunier ◽  
Kurt B. Angstman ◽  
Kathy L. MacLaughlin ◽  
Sara S. Oberhelman ◽  
James E. Rohrer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document